What Researchers Did
Researchers conducted a prospective observational study comparing hyperbaric oxygen (HBO) therapy to normobaric oxygen (NBO) therapy for preventing delayed neuropsychiatric sequelae (DNS) in 224 patients with acute carbon monoxide poisoning, using propensity score matching.
What They Found
Out of 224 patients, 40 developed DNS. Initially, the incidence of DNS was 19.2% in the HBO group (198 patients) compared to 7.7% in the NBO group (26 patients), but this difference was not statistically significant (p = 0.18). After propensity score matching, the incidence of DNS remained similar between the NBO and HBO groups (8.3% vs. 10.4%, p > 0.99).
What This Means for Canadian Patients
For Canadian patients experiencing acute carbon monoxide poisoning, this study suggests that hyperbaric oxygen therapy may not be more effective than normobaric oxygen therapy in preventing delayed neuropsychiatric sequelae. This implies that current treatment protocols for CO poisoning may not need to prioritize HBO specifically for DNS prevention.
Canadian Relevance
There is no direct Canadian connection to this study, as it was conducted in a tertiary hospital outside of Canada.
Study Limitations
The study was an observational design, which, despite propensity score matching, may still be subject to unmeasured confounding variables.